Sage Journals: Discover world-class research

Retricted access

Research article

First published 2013-2

Crizotinib: A New Treatment Option for ALK -Positive Non-Small Cell Lung Cancer

Cindy L O'Bryant, Sarah D Wenger, Miryoung Kim [...]

Annals of Pharmacotherapy

Free access

Review article

First published 2015-9

Treating patients with ALK -positive non-small cell lung cancer: latest evidence and management strategy

Bin-Chi Liao, Chia-Chi Lin, Jin-Yuan Shih [...]

Therapeutic Advances in Medical Oncology

Free access

Research article

First published 2025-2

Development of an ALK-positive Non-Small-Cell Lung Cancer in Vitro Tumor 3D Culture Model for Therapeutic Screening

Madeleine A. Berry, Abigail R. Bland, Gretel S. Major [...]

Journal of Histochemistry & Cytochemistry

Open access

Research article

First published 2021-2

Different clinical features between patients with ROS1 -positive and ALK -positive advanced non-small cell lung cancer

Xianxiu Ji, Huikang Xie, Ren Zhu [...]

Journal of International Medical Research

Open access

Review article

First published 2019

Alectinib in the treatment of ALK-positive metastatic non-small cell lung cancer: clinical trial evidence and experience with a focus on brain metastases

Pascale Tomasini, Julie Egea, Maxime Souquet-Bressand [...]

Therapeutic Advances in Respiratory Disease

Retricted access

Case report

First published 2019-12

Complete remission for 4 years with crizotinib in advanced ALK-positive non-small cell lung cancer after thoracostomy for empyema

Eufra Van Damme, Maja Kiselinova, Elke Van Schoote

Tumori Journal

Open access

Research article

First published 2023-9

Economic burden in patients with anaplastic lymphoma kinase ( ALK )-positive non-small cell lung cancer (NSCLC),with or without brain metastases,receiving first-line ALK inhibitors

Yanyu Wu, Kaili Ren, Yin Wan [...]

Journal of Oncology Pharmacy Practice

Retricted access

Research article

First published 2022-4

Brigatinib is a cost-effective treatment in first-line anaplastic lymphoma kinase mutation-positive (ALK + ) advanced non-small cell lung cancer (NSCLC) with brain metastases

Jacopo Giuliani

Journal of Oncology Pharmacy Practice

Free access

Review article

First published 2015-10

The efficacy of ceritinib in patients with ALK -positive non-small cell lung cancer

John Kaczmar, Ranee Mehra

Therapeutic Advances in Respiratory Disease

Retricted access

Research article

First published 2012-07

EML4-ALK-Positive Non-Small Cell Lung Cancer in a Patient Treated with Azathioprine for Ulcerative Colitis

Irena Lazarev, Netta Sion-Vardy, Samuel Ariad

Tumori Journal

Search results